All research
Tirzepatide 2026-10-27 PubMed

Weight-Loss Magnitude, Fat Mass, and Device-Estimated Muscle Mass Loss During Obesity Pharmacotherapy.


Summary withdrawn

TitrateLab removes an AI-written study summary when it states findings we cannot trace to the study's own record, or when the study falls outside the compounds we track. Read the original record through the link above.


tirzepatide semaglutide obesity weight loss body composition muscle mass
Source: pubmed:42941522 · Ingested Oct 27, 2026